Sanofi (SNY) Current Taxes (2015 - 2026)
Sanofi (SNY) posted Current Taxes of $1.0 billion for Q2 2026, up 17.54% sequentially from $874.2 million in Q4 2025, and up 25.38% YoY from $819.5 million in Q2 2025.
Sanofi (SNY) Current Taxes (2015 - 2026) Analysis & Trends
Sanofi has reported Current Taxes for 12 years, with the latest figure at $1.0 billion in Q2 2026.
- Quarterly Current Taxes rose 25.38% year-over-year to $1.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.0 billion (up 25.38% YoY) and the FY2025 annual result came in at $874.2 million, up 17.37% from the prior year.
- Current Taxes advanced to $1.0 billion in Q2 2026 per SNY's latest filing, from $874.2 million in the prior quarter.
- Over five years, Current Taxes peaked at $1.0 billion in Q2 2026 and troughed at $142.1 million in Q2 2024.
- A 5-year average of $635.5 million and a median of $642.3 million in 2023 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2024 and 2025: Current Taxes plunged 65.37% in 2024, then surged 476.53% in 2025.
- Over 5 years, Current Taxes stood at $585.6 million in 2022, then rose by 9.68% to $642.3 million in 2023, then rose by 15.95% to $744.8 million in 2024, then rose by 17.37% to $874.2 million in 2025, then gained by 17.54% to $1.0 billion in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $1.0 billion, $874.2 million, and $819.5 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.32 Bn | 632.56 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 470.11 Bn | 463.54 Bn | 12.70 Bn | - |
| 3 | Merck | 376.14 Bn | 369.00 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 303.26 Bn | 295.57 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 257.39 Bn | 252.49 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 236.59 Bn | 222.60 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.91 Bn | 178.73 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.26 Bn | 147.57 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 106.16 Bn | 101.99 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Sanofi | 55.11 Bn | 47.73 Bn | 10.79 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Bn |
| Dec 31, 2025 | 874.20 Mn |
| Jun 30, 2025 | 819.54 Mn |
| Dec 31, 2024 | 744.81 Mn |
| Jun 30, 2024 | 142.15 Mn |
| Dec 31, 2023 | 642.34 Mn |
| Jun 30, 2023 | 410.52 Mn |
| Dec 31, 2022 | 585.62 Mn |
| Jun 30, 2022 | 472.71 Mn |
| Dec 31, 2021 | 353.49 Mn |
| Jun 30, 2021 | 708.11 Mn |
| Dec 31, 2020 | 720.14 Mn |
| Dec 31, 2019 | 285.58 Mn |
| Dec 31, 2018 | 447.43 Mn |
| Dec 31, 2017 | 1.39 Bn |
| Dec 31, 2016 | 1.22 Bn |
| Dec 31, 2015 | 1.14 Bn |